Nasopharyngeal carcinoma future or investigational therapies

Jump to: navigation, search

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma future or investigational therapies

CDC on Nasopharyngeal carcinoma future or investigational therapies

Nasopharyngeal carcinoma future or investigational therapies in the news

Blogs on Nasopharyngeal carcinoma future or investigational therapies

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Treatments under clinical evaluation for patients with nasopharyngeal cancer include dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost and brachytherapy.[1]

Future Treatment

Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following:[1]

  • Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost
  • Brachytherapy

References

  1. 1.0 1.1 Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE; et al. (1999). "Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control.". Int J Radiat Oncol Biol Phys. 45 (4): 915–21. PMID 10571198. 

Linked-in.jpg